HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Wednesday, 21 March 2012

Recent CUAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers.  48 papers were listed this time. Here's a few in our areas of research interest:

Gajic-Veljanoski O, Bayoumi AM, Tomlinson G, et al. Vitamin K supplementation for the primary prevention of osteoporotic fractures: is it cost-effective and is future research warranted? Osteoporos Int. 2012 Mar 8. [Epub ahead of print] PubMed PMID: 22398856.

Erhardt W, Bergenheim K, Duprat-Lomon I, at al. Cost Effectiveness of Saxagliptin and Metformin versus Sulfonylurea and Metformin in the Treatment of Type 2 Diabetes Mellitus in Germany: A Cardiff Diabetes Model Analysis. Clin Drug Investig. 2012 Mar 1;32(3):189-202. PubMed PMID: 22292415.

Valentine WJ, Jendle J, Saraheimo M, et al. Evaluating the cost- effectiveness of reduced mild hypoglycaemia in subjects with Type 1 diabetes treated with insulin detemir or NPH insulin in Denmark, Sweden, Finland and the Netherlands. Diabet Med. 2012 Mar;29(3):303-12. PubMed PMID: 21951030.

Davies MJ, Chubb BD, Smith IC, et al. Cost-utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add-on to metformin monotherapy in Type 2 diabetes mellitus. Diabet Med. 2012 Mar;29(3):313-20. PubMed PMID: 21883438.

De Smedt D, De Cocker K, Annemans L, et al. A cost-effectiveness study of the community-based intervention '10 000 Steps Ghent'. Public Health Nutr. 2012 Mar;15(3):442-51. Epub 2011 Aug 23. PubMed PMID: 21859505.